Cardio Diagnostics (NASDAQ:CDIO – Get Free Report) posted its quarterly earnings data on Friday. The company reported ($0.59) earnings per share for the quarter, Zacks reports. Cardio Diagnostics had a negative return on equity of 82.28% and a negative net margin of 43,133.33%.
Cardio Diagnostics Stock Performance
Shares of Cardio Diagnostics stock opened at $1.68 on Friday. The firm has a market capitalization of $4.96 million, a PE ratio of -0.66 and a beta of 2.32. The firm’s 50 day moving average is $1.84 and its 200 day moving average is $2.06. Cardio Diagnostics has a 1 year low of $0.97 and a 1 year high of $7.91.
Analysts Set New Price Targets
Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Cardio Diagnostics in a research report on Tuesday, September 8th. One equities research analyst has rated the stock with a Sell rating. According to MarketBeat.com, Cardio Diagnostics currently has a consensus rating of “Sell”.
About Cardio Diagnostics
Cardio Diagnostics Holdings, Inc is a biotechnology company developing artificial intelligence-powered precision medicine products for the prevention and management of cardiovascular disease. Its approach combines genetic, epigenetic and clinical information to help identify individuals at elevated risk and support more personalized care.
The company’s product portfolio includes Epi+Gen CHD, a blood-based test designed to assess an individual’s risk of developing coronary heart disease and provide information that may guide prevention strategies.
See Also
- Five stocks we like better than Cardio Diagnostics
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Receive News & Ratings for Cardio Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardio Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.
